SCHEMBL9942590

SCHEMBL9942590

Bc1nccc2cc[nH]c12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 1/20 0.43
GRM5 P41594 2/20 0.41
AXL P30530 2/20 0.39
NUDT1 P36639 2/20 0.39
KEAP1 Q14145 1/20 0.38
PDPK1 O15530 1/20 0.37
TNF P01375 1/20 0.36
RIPK1 Q13546 1/20 0.36
BRD4 O60885 1/20 0.34
TAF1 P21675 1/20 0.34
BRPF1 P55201 1/20 0.34
CREBBP Q92793 1/20 0.34
CECR2 Q9BXF3 1/20 0.34
BRD9 Q9H8M2 1/20 0.34
NR3C1 P04150 1/20 0.34
PGR P06401 1/20 0.34
NR3C2 P08235 1/20 0.34
AR P10275 1/20 0.34
BACE1 P56817 1/20 0.33
PRKCI P41743 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23233865 0.77 GRM5 (0.41) AHRGRM5AXLNUDT1KEAP1
SCHEMBL30678614 0.76 GRM5 (0.43) AHRGRM5AXLNUDT1KEAP1
SCHEMBL762091 0.76 DYRK1A (0.48) AHRGRM5AXLNUDT1KEAP1
SCHEMBL30781502 0.76 TNF (0.44) AHRGRM5AXLNUDT1KEAP1
SCHEMBL652414 0.76 GRM5 (0.40) AHRGRM5AXLNUDT1KEAP1
SCHEMBL401223 0.76 NOS3 (0.42) AHRGRM5AXLNUDT1KEAP1
SCHEMBL1154874 0.76 GRM5 (0.43) AHRGRM5AXLNUDT1KEAP1
SCHEMBL2633337 0.76 GRM5 (0.43) AHRGRM5AXLNUDT1KEAP1
SCHEMBL30122523 0.76 DYRK1A (0.48) AHRGRM5AXLNUDT1KEAP1
SCHEMBL18237616 0.72 GRM5 (0.38) AHRGRM5AXLNUDT1KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1363705-B9 COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES BRISTOL MYERS SQUIBB CO (US) 2012-11-07 EP disclosed
EP-1363705-B1 COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES BRISTOL MYERS SQUIBB CO (US) 2012-06-13 EP disclosed